Prospective Efficacy of Osimertinib in Circulating Tumour DNA (ctDNA) (TM)-M-790-Mutant NSCLC Patients-MedSci.cn

Prospective Efficacy of Osimertinib in Circulating Tumour DNA (ctDNA) (TM)-M-790-Mutant NSCLC Patients

Remon, J; Jovelet, C; Lacroix, L; Planchard, D; Mezquita, L; Howarth, K; Green, E; Plagnol, V; Morris, C; Rosenfeld, N; Caramella, C; Lepechoux, C; Nana, FA; Botticella, A; Adam, J; Ferrara, R; Gazzah, A; Ngocamus, M; Soria, J; Besse, B

JOURNAL OF THORACIC ONCOLOGY, 2018; 13 (10): S807

科室
- - 订阅+
  - 更多科室
工具
服务